These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 32971314

  • 1. Quality of life after response to acute-phase cognitive therapy for recurrent depression.
    Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2021 Jan 01; 278():218-225. PubMed ID: 32971314
    [Abstract] [Full Text] [Related]

  • 2. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.
    Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME.
    JAMA Psychiatry; 2013 Nov 01; 70(11):1152-60. PubMed ID: 24005123
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Affect Disord; 2016 Jul 15; 199():148-56. PubMed ID: 27104803
    [Abstract] [Full Text] [Related]

  • 4. Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
    Vittengl JR, Clark LA, Smits JAJ, Thase ME, Jarrett RB.
    J Affect Disord; 2019 Jan 01; 242():150-158. PubMed ID: 30176494
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychol Med; 2015 Nov 01; 45(15):3191-204. PubMed ID: 26098793
    [Abstract] [Full Text] [Related]

  • 7. Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychotherapy (Chic); 2015 Jun 01; 52(2):268-77. PubMed ID: 25985046
    [Abstract] [Full Text] [Related]

  • 8. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2014 Dec 01; 82(6):1049-59. PubMed ID: 25045908
    [Abstract] [Full Text] [Related]

  • 9. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Anna Clark L, Thase ME, Jarrett RB.
    Psychiatry Res; 2017 Jul 01; 253():174-181. PubMed ID: 28388454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How much cognitive therapy, for which patients, will prevent depressive relapse?
    Jarrett RB, Vittengl JR, Clark LA.
    J Affect Disord; 2008 Dec 01; 111(2-3):185-92. PubMed ID: 18358541
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Behav Res Ther; 2016 Dec 01; 87():48-57. PubMed ID: 27591917
    [Abstract] [Full Text] [Related]

  • 16. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
    Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.
    J Clin Psychopharmacol; 2002 Oct 01; 22(5):474-80. PubMed ID: 12352270
    [Abstract] [Full Text] [Related]

  • 17. Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.
    Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2014 Oct 01; 167():37-43. PubMed ID: 25082112
    [Abstract] [Full Text] [Related]

  • 18. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
    Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC.
    Arch Gen Psychiatry; 2001 Apr 01; 58(4):381-8. PubMed ID: 11296099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.